Showing 1111-1120 of 21420 results for "".
- Picosecond Laser Study Links Immediate Whitening to Skin Tissue Responsehttps://reachmd.com/news/picosecond-laser-study-links-immediate-whitening-to-skin-tissue-response/2488179/A new in vivo study offers a closer look at what immediate whitening (IW) may represent at the tissue level following picosecond laser irradiation. Researchers publishing in Lasers in Surgery and Medicine, the study evaluated the relationship among IW, vacuole formation, and melan
- Carotid IPN on Ultrasound Linked to Cerebral Microbleedshttps://reachmd.com/news/carotid-ipn-on-ultrasound-linked-to-cerebral-microbleeds/2488148/Key Takeaways Among neurology inpatients with carotid plaque at a single center in Hefei, China, cerebral microbleeds were detected on susceptibility-weighted brain magnetic resonance imaging. Higher carotid intraplaque neovascularization grade was significantly asso
- Severe Mental Illness Linked to Dementia and Stroke Riskhttps://reachmd.com/news/severe-mental-illness-dementia-stroke-risk/2488141/Key Takeaways In the large Catalonia PADRIS-PRESTO health-records cohort, severe mental illness was associated with dementia across adulthood. The largest relative dementia gap appeared in younger adults, even though absolute prevalence in that age range remained low
- INTerpath-001: Intismeran Plus Pembrolizumab Meets Dual Phase 3 Melanoma Endpointshttps://reachmd.com/news/intismeran-plus-pembrolizumab-meets-dual-phase-3-melanoma-endpoints/2488176/Merck and Moderna reported positive topline results from the phase 3 INTerpath-001 trial evaluating intismeran autogene (V940; mRNA-4157) plus pembrolizumab (Keytruda) as adjuvant therapy for completely resected stage IIB-IV cutaneous melanoma. The individualized mRNA-based neoantigen ther
- Digital CBT Improves Childhood Anxiety Over 2 Yearshttps://reachmd.com/news/digital-cbt-improves-childhood-anxiety-over-2-years/2488129/Key Takeaways School-screened Finnish children aged 10 to 13 years with anxiety symptoms had greater improvement with Master Your Worries than with digital educational materials alone. Functional ability improved more with the intervention than with the control condi
- COPD ICS Dosing Linked to No Added CV Riskhttps://reachmd.com/news/copd-ics-dosing-linked-to-no-added-cv-risk/2488133/Key Takeaways In a very large Danish cohort with specialist-verified COPD and no prior cardiovascular event history, 8,948 patients experienced a cardiovascular event during 1 year of follow-up, an event burden of 10.9%. Low- and moderate-dose ICS were associated wit
- Early PEEP Linked to Mortality in Sepsis-Associated Myocardial Injuryhttps://reachmd.com/news/early-peep-mortality-sepsis-associated-myocardial-injury/2488123/Key Takeaways In a retrospective cohort of 3,421 mechanically ventilated adults with sepsis-associated myocardial injury, higher early TWA PEEP was associated with higher intensive care unit and in-hospital mortality. A 285-patient external cohort showed the same dir
- AbbVie Names 34 Immunology Scholarship Recipients for 2026https://reachmd.com/news/abbvie-names-34-immunology-scholarship-recipients-for-2026/2488127/AbbVie has announced 34 recipients of its 2026 AbbVie Immunology Scholarship, according to a news release, marking the 10th year of a program designed to support students living with chronic inflammatory diseases as they pursue higher education. Since the scholarship launched in 2016, AbbV
- Occupational Exposures Implicated in More Than Half of Chronic Hand Eczema Caseshttps://reachmd.com/news/occupational-exposures-implicated-in-more-than-half-of-chronic-hand-eczema-cases/2488120/A new retrospective study of adults with chronic hand eczema (CHE) found allergic contact dermatitis (ACD) and occupational exposures were common, while most patients improved following diagnosis and treatment recommendations that included allergen avoidance. Investigators evaluated 76 adu
- BACE Added to Tislelizumab Improved Response in Bulky NSCLChttps://reachmd.com/news/bace-added-to-tislelizumab-improved-response-in-bulky-nsclc/2488114/Key Takeaways In inoperable, driver-negative stage IIIB-IVB non-small cell lung cancer (NSCLC) with primary tumors at least 50 mm, a first-line sequential bronchial arterial chemoembolization (BACE)-containing regimen with tislelizumab was associated with higher response than